HEALTHTAB
LIVE

Serial Number

97096687

Owner

HealthTab Inc.

Attorney

Leigha R. Santoro

Filing Date

Oct 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HEALTHTAB Trademark

Serial Number: 97096687 • Registration: 7924315

HEALTHTAB is a trademark filed by HealthTab Inc. on October 28, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HealthTab Inc. (2 trademarks)

302 - 2083 Alma Street
Vancouver, BC V6R4N6 , CA

Entity Type: 03

Trademark Details

Filing Date

October 28, 2021

Registration Date

September 2, 2025

Published for Opposition

July 15, 2025

Goods & Services

Computer hardware and downloadable software for receiving, processing, transmitting, and displaying data from medical testing devices, namely, blood pressure monitors and scales; downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, blood pressure, height, weight, and patient lifestyle information; Computer hardware and downloadable software for receiving, processing, transmitting, and displaying data from medical testing devices, namely, in vitro diagnostic devices; downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, test results from in vitro diagnostic devices

Providing temporary use of on-line non-downloadable software for receiving, processing, transmitting, and displaying data from medical testing devices, namely, blood pressure monitors and scales; providing temporary use of on-line non-downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, blood pressure, height, weight, and patient lifestyle information; providing temporary use of on-line non-downloadable software for receiving, processing, transmitting, and displaying data from medical testing devices, namely, in vitro diagnostic devices; providing temporary use of on-line non-downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, test results from in vitro diagnostic devices

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 2, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 2, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 13, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 27, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 30, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 30, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 30, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 4, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 8, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 8, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 8, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 17, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
May 17, 2024 GNSL
SUSPENSION LETTER WRITTEN
May 17, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 29, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 1, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 1, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 1, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 4, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 4, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 4, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 1, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 3, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 3, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
May 3, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 3, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 3, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 3, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2022 CRFA
ASSIGNED TO LIE
Oct 7, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2022 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Aug 12, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Aug 12, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Aug 12, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Aug 12, 2022 CPEA
ASSIGNED TO EXAMINER
Aug 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2021 NWOS
NEW APPLICATION ENTERED
Nov 1, 2021 NWAP